S.C. Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.96M Buy
12,133
+238
+2% +$36.5K 3.01% 5
2022
Q3
$1.6M Sell
11,895
-942
-7% -$135K 2.53% 7
2022
Q2
$1.97M Buy
12,837
+56
+0.4% +$8.56K 3.02% 5
2022
Q1
$2.07M Buy
12,781
+53
+0.4% +$7.7K 2.66% 5
2021
Q4
$1.7M Buy
+12,728
New +$1.5M 1.95% 8

Other funds holding ABBV

S.C. Financial Services's ABBV Position: Q4 2022 in Review

S.C. Financial Services increased its AbbVie (ABBV) stake by 2% in Q4 2022, buying an estimated $36.5K and bringing the position to 12,133 shares worth $1.96M. The position accounts for 3.01% of the portfolio, ranked #5.

S.C. Financial Services first reported a position in ABBV in Q4 2021 and has held it in 5 quarters since. The position peaked at $2.07M in Q1 2022. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • S.C. Financial Services held 12,133 shares of AbbVie worth $1.96M as of Q4 2022.
  • S.C. Financial Services bought 238 AbbVie shares in Q4 2022, an estimated $36.5K.
  • AbbVie made up 3.01% of S.C. Financial Services's portfolio in Q4 2022, its #5 holding.
  • S.C. Financial Services first reported a position in AbbVie in Q4 2021 and has held it in 5 quarters since.
  • S.C. Financial Services's AbbVie position peaked at $2.07M in Q1 2022.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on S.C. Financial Services's 13F filing for Q4 2022, filed 20 Jan 2023.